fda9d053855e19af8b8fc2571cd7caba:6e13f2473002296e620b871fc2571e061d9a851b3522d35968f9ccbca7e8a0d77992104ff92da1b8d5d94c353581337ba8f31148bbd24e472642d43d0224f652ab819e4a4df2230f3d3ef2458a703f59b7d6930314cd59f557806e8850851a00bb684aee5f6eeab8b53d0fd2623137d7590474598fc684a677316055b1829fdd9b03f5b24ac0bd5b7335f80484a5471eb81399844005759d4db570e38e7c41ef3e6e3ad694b5f174c83c5147fe07cef730f0251ffbdffdecce0cb879da707fbdced7da72ff30e57fc2cd19cec9d9d3fbb979b23ff6d05c646acf3fe9fcbd6b4b0fae81951b0c288e0ccc408489456bcdc70f9c2ff8a56eae452d92e53a0e2ab6f0463cbf7a441497c02fa12ab667bcf062fafe23cbeea7ed1a964d4db4a265bba5d597661f3c5a223a7539390897003715eb04785a9d56a0832792954ec430a86d9d50100f3727b539b79e11bcf00344ebd8778806a0a504aa9eb07e41397e00c68a56341fefb28c92fc1ba292051fc74ff2a49f507c27b7f009491a6a2ec5e6664e9ac3226718207e932dcaa23874969732ce0e59f37006f9458782080c5d